Existing Cancer Therapy Demonstrates Significant Effect Against Other Cancers: Study

Contact Your Elected Officials
The Epoch Times Header

An approved cancer therapeutic, once used in only 1 percent of cancers, may have significant uses in the remaining 99 percent, according to a new study.

โ€œIvosidenib, previously called AG-120, may be applicable to the large majority of cancers,โ€ said senior author Dr. Jordan Winter, division chief of surgical oncology at University Hospitals Seidman Cancer Center in Cleveland.

Winter said that the therapeutic was previously used in the โ€œ1 percentโ€ of cancers that carried a mutation, or change, in the IDH1 gene. However, scientists now believe it can also be used in the โ€œremaining 99 percentโ€ in cancer cells that carry the wild-type, or normal, IDH1 gene, under conditions that the environment is low in magnesium.

The IDH1 gene is very critical for cancer cells living in a harsh and nutrient-deprived environment.

โ€œWhen the cancer cells have less oxygen and less glucose or glutamine, anything that hurts them, they need a defense mechanism to protect them, which is this important molecule IDH1,โ€ said Dr. Ali Vaziri-Gohar, the lead author of the study,ย which was published on June 9.

In nutrient-deprived environments, IDH1 will activate, producing proteins that will neutralize the reactive oxygen species that are produced in this specific environment. If the reactive species are not neutralized, they will cause damage to cells, resulting in the stunting of growth of cancer cells and their death.

Ivosidenib, which has been approved by the Food and Drug Administration (FDA), was previously used to inhibit the mutated version of IDH1 in pancreatic cancer, so that cancers will be sensitized and die.

However, now that the researchers have identified its potency against wild-type IDH1 cancers, they have hopes that the therapeutic may be used against a wider range of cancers.

Some IDH1 cancers are acute myeloid leukemia, a cancer of the immune cells that is already being treated by this therapeutic, as well as brain cancer, though there are many others.

However, the study into Ivosidenib in cancer cultures has shown that it is at its most potent only under low magnesium concentrations, as magnesium prevents inhibition of IDH1.

Therefore, only under low magnesium concentrations can the drug inhibit IDH1, causing damage to the cells that are reliant on IDH1 to protect them.

The researchers also found that complete removal of the IDH1 gene from mice did not impact the wellness of the animal at the baseline, but made the mice more vulnerable to liver injury at sublethal doses of fat, suggesting partial safety of the treatment.

This finding highlights that the use of Ivosidenib as a cancer therapeutic to inhibit IDH1 in humans to stunt cancer growthโ€”which in the worse case scenario, is akin to removing all the IDH1 genes from the bodyโ€”may be safe for use in humans.

Given that Ivosidenib is already approved by the FDA for IDH1 mutant cancers, the researchers are optimistic about its approval and use in other IDH1 cancers.

โ€œIn our hands and in pre-clinical models, wild-type IDH1 represents a true metabolic vulnerability in cancer cells and is a bona fide therapeutic target across a wide range of wild-type IDH1 cancers,โ€ said Winter.

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

Democrats Are In Disastrous Shape As Midterms Loom

According to CNN's Harry Enten, โ€œThe Democratic brand is in the basement. It is total and complete garbage in the mind of the American public.โ€

A Primer on Conservatism

Conservatism is based on the maintenance and preservation of economic and governmental liberty of the individual citizen to choose what is best for their interests.

Woke Verses Folk Marketing Mayhem

For purposes of this article woke is about 10% of our population while folk is defined as the remaining 90% of our population.ย 

Late nightโ€™s Javan Rhino ย 

Once upon a time in America, late-night television talk shows were nightly viewing for many following their local news.

MyPillowโ€™s CEO Mike Lindell Wins 2 Court Cases

A federal court tossed the $5M ruling against Mike Lindell, saying arbitrators rewrote the rules of his 2021 Cyber Symposium challenge.

Trump Orders Nuclear Submarines Moved After Former Russian Presidentโ€™s Comments

Trump confirmed he ordered two Nuclear Submarines to be positioned in appropriate regions, in case Putin's inflammatory statements are more than just that.

American Eagle Responds to Critics Over Ad With Sydney Sweeney

In a statement posted on American Eagleโ€™s Instagram account on Friday, the retailer said the ad campaign โ€œis and always was about the jeans.

What to Know About 7-OH, the Synthetic Opioid Derived From Kratom Facing an FDA Ban

Synthetic opioid derived from the kratom plant sold in gummies, tablets, and drink mixes is to be restricted due to concerns it has serious potential for abuse.

Wall Street Review: Stocks Sell Off Amid Confusion Over Economic Data and Fed Policy

After all-time highs for a couple of weeks, U.S. equities retreated on profit-taking and confusion over direction of U.S. economy and monetary policy.

Tariff Rates โ€˜Pretty Much Set,โ€™ Says US Trade Representative

President Trumpโ€™s trade representative, Jamieson Greer, said that Americans should expect the administrationโ€™s tariff levels to remain where they are.

White House Officials Say Trump Had โ€˜Real Concernsโ€™ With Top Labor Official Before Firing Her

White House officials said it was necessary to fire former Bureau of Labor Statistics head Erika McEntarfer following release of lower-than-expected jobs report.

Trump Admin Cancels $26 Million Funding for Baltimore-DC Maglev Train Project

The FRA will cancel two grants worth more than $26 million for the Baltimore-Washington Superconducting Magnetic Levitation (SCMAGLEV) project.

Senate Confirms Former Fox News Host Jeanine Pirro as US Attorney for DC

The U.S. Senate confirmed former Fox News host and political commentator Jeanine Pirro to serve as the U.S. attorney for the District of Columbia.
spot_img

Related Articles